A tug-of-war between the host and the pathogen generates strategic hotspots for the development of novel therapeutic interventions against infectious diseases

Virulence

Volumn 6, Issue 6, 2015, Pages 566-580

  Rana, Aarti ^a   Ahmed, Mushtaq ^a   Rub, Abdur ^b   Akhter, Yusuf ^a  

^a CENTRAL UNIVERSITY OF HIMACHAL PRADESH   (India)

^b JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

Author keywords

Actin remodelling; Host pathogen interaction; PAMPs; PRRs; Signaling cascades

Indexed keywords

AMPHOTERICIN B; ANTIINFECTIVE AGENT; C TYPE LECTIN RECEPTOR; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; CD36 ANTIGEN; DECTIN 1; DECTIN 2; FORMYLPEPTIDE RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; LECTIN RECEPTOR; LIPOPOLYSACCHARIDE BINDING PROTEIN; LIPOPROTEIN; LIPOTEICHOIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN; PATHOGEN ASSOCIATED MOLECULAR PATTERN; PATTERN RECOGNITION RECEPTOR; PENTRAXIN; PROTEIN BCL 10; RETINOIC ACID INDUCIBLE PROTEIN I; SURFACTANT ASSOCIATED PROTEIN; SURFACTANT PROTEIN A; SURFACTANT PROTEIN A 1; SURFACTANT PROTEIN A 2; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; IMMUNOLOGIC FACTOR;

ANTIGEN RECOGNITION; ARTICLE; BACTERIAL INFECTION; CHLAMYDIA; CHLAMYDIA CAVIAE; CHLAMYDIA PNEUMONIAE; DISEASE COURSE; ENZYME ACTIVITY; GENE; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; INFECTION; INFLAMMATION; INNATE IMMUNITY; LIGAND BINDING; MACROAUTOPHAGY; MOLECULAR BIOLOGY; MOLECULAR PATHOLOGY; MYCOSIS; NONHUMAN; OLIGOMERIZATION; PROTEIN DEGRADATION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STIMULATOR OF INTERFERON GENE; VIRUS CELL INTERACTION; ADAPTIVE IMMUNITY; COMMUNICABLE DISEASES; IMMUNIZATION; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; PATHOLOGY; PROCEDURES;

ADAPTIVE IMMUNITY; ANTI-INFECTIVE AGENTS; COMMUNICABLE DISEASES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; IMMUNIZATION; IMMUNOLOGIC FACTORS; PATHOGEN-ASSOCIATED MOLECULAR PATTERN MOLECULES; RECEPTORS, PATTERN RECOGNITION; SIGNAL TRANSDUCTION;

EID: 84954526940     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.1080/21505594.2015.1062211     Document Type: Article

References (101)

1. Basset C, Holton J, O’Mahony R, Roitt I. Innate immunity and pathogen-host interaction. Vaccine 2003; 21:S12-S23; PMID:12763678; http://dx.doi.org/10.1016/S0264-410X(03)00195-6
2. Carabeo R. Bacterial Subversion of Host Actin Dynamics at the Plasma Membrane. Cell Microbiol 2011; 13:1460-1469; PMID:21790944; http://dx.doi.org/10.1111/j.1462-5822.2011.01651.x
3. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 2000; 406:782-787; PMID:10963608; http://dx.doi.org/10.1038/35021228
4. Cdllb CR, Ishibashi BY, Claus S, Relman DA. Borde- tella pertussis filamentous hemagglutinin interacts with a leukocyte signal transduction complex and stimulates bacterial adherence to monocyte CR3 (CDllb/CD18). J. Exp. Med 1994; 180:1225-33.
5. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010; 140:805-20; PMID:20303872; http://dx.doi.org/10.1016/j.cell.2010.01.022
6. Lien E, Sellati TJ, Yoshimura A, Flo TH, Rawadi G, Finberg RW, Carroll JD, Espevik T, Ingalls RR, Radolf JD, Golenbock DT. Toll-like Receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J. Biol. Chem. 1999; 274:33419-33425; PMID:10559223; http://dx.doi.org/10.1074/ jbc.274.47.33419
7. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll. Nature 2001; 413:732-8; PMID:11607032; http://dx.doi.org/10.1038/35099560
8. Beutler B. Tlr4:central component of the sole mammalian LPS sensor. Curr Opin Immunol. 2000; 12:20-6; PMID:10679411; http://dx.doi.org/10.1016/S0952-7915(99)00046-1
9. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, Eng JK, Akira S, Underhill DM, Aderem A. Hayashi F, et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001; 410:1099-103; PMID:11323673; http://dx.doi.org/10.1038/35074106
10. Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, Hoshino K, Horiuchi T, Tomizawa H, Takeda K, Akira S. Small anti-viral compounds activate immune cells via the TLR7 MyD88- dependent signaling pathway. Nat. Immunol. 2002; 3:196-200; PMID:11812998; http://dx.doi.org/10.1038/ni758
11. Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, Hoshino K, Matsumoto M, Hoshino K, Wagner H, Takeda K et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408:740-5; PMID:11130078; http://dx.doi.org/10.1038/35047123
12. Blasius AL, Beutler B. Intracellular toll-like receptors. Immunity 2010; 32:305-15; PMID:20346772; http://dx.doi.org/10.1016/j.immuni.2010.03.012
13. Zhang D, Zhang G, Hayden MS, Greenblatt MB, Bussey C, Flavell RA, Ghosh S. A toll-like receptor that prevents infection by uropathogenic bacteria. Science 2004; 303:1522-6; PMID:15001781; http://dx.doi.org/10.1126/science.1094351
14. Koblansky AA, Jankovic D, Oh H, Hieny S, Sungnak W, Mathur R, Hayden MS, Akira S, Sher A, Ghosh S. Recognition of profilin by Toll-like Receptor 12 is critical for host resistance to Toxoplasma gondii. Immunity 2013; 38:119-30; PMID:23246311; http://dx.doi.org/10.1016/j.immuni.2012.09.016
15. Lee BL, Moon JE, Shu JH, Yuan L, Newman ZR, Schekman R, Barton GM. UNC93B1 mediates differential trafficking of endosomal TLRs. Elife 2013; 2: e00291; PMID:23426999
16. Yoneyama M, Fujita T. RNA recognition and signal transduction by RIG-I-like receptors. Immunol. Rev. 2009; 227:54-65; PMID:19120475; http://dx.doi.org/10.1111/j.1600-065X.2008.00727.x
17. Loo YM, Gale M Jr. Immune signaling by RIG-I-like receptors. Immuntiy 2011; 34:680-692; http://dx.doi.org/10.1016/j.immuni.2011.05.003
18. Janeway CA, Medzhitov R. Innate immune recognition. Immunology 2002; 20:197-216; http://dx.doi.org/10.1146/annurev.immunol.20.083001.084359
19. Kingeter LM, Lin X. C-type lectin receptor-induced NF-kB activation in innate immune and inflammatory responses. Cell. Mol. Immunol. 2012; 9:105-12; PMID:22246129; http://dx.doi.org/10.1038/cmi. 2011.58
20. Yamasaki S, Sho Matsumoto M, Takeuchi O, Matsu- zawa T, Ishikawa E, Sakuma M, Tateno H, Uno J, Hirabayashi J, et al. C-type lectin Mincle is an activating receptor for pathogenic fungus, Malassezia. PNAS 2009; 106:1897-902; PMID:19171887; http://dx.doi.org/10.1073/pnas.0805177106
21. Cummings RD, McEver RP. C-type Lectins. In:Essentials of Glycobiology. 2nd ed. Cold Spring Harbor, NY: 2009; Chap. 31.
22. Murphy JE, Tedbury PR, Homer-Vanniasinkam S, Walker JH, Ponnambalam S. Biochemistry and cell biology of mammalian scavenger receptors. Atherosclerosis 2005; 182:1-15; PMID:15904923; http://dx.doi.org/10.1016/j.atherosclerosis.2005.03.036
23. Prabhudas M, Bowdish D, Drickamer K, Febbraio M, Herz J, Kobzik L, Krieger M, Loike J, Means TK, Moestrup SK, Post S, Sawamura T, Silverstein S, Wang XY, El Khoury J. Standardizing Scavenger Receptor Nomenclature. J Immunol. 2014; 192:1997-2006; PMID:24563502; http://dx.doi.org/10.4049/jimmunol.1490003
24. Areschoug T, Gordon S. Scavenger receptors: Role in innate immunity and microbial pathogenesis. Cell.Microbiol. 2009; 11:1160-1169; PMID:19388903; http://dx.doi.org/10.1111/j.1462-5822.2009.01326.x
25. Leslie RGQ, Hansen S. Complement Receptors. Complement Receptors. eLS 2009; http://dx.doi.org/10.1002/9780470015902.a0000512.pub2
26. Le Y, Murphy PM, Wang JM. Formyl-peptide receptors revisited. Trends Immunol. 2002; 2:541-8; http://dx.doi.org/10.1016/S1471-4906(02)02316-5
27. Boss JM, Howard I, Medica H. &Schreiber, S. The NLR gene family:An official nomenclature. Immunity 2009; 28:285-287
28. Cruyssen BV, Peeters H, Hoffman IEa, Laukens D, Coucke P, Marichal D, Cuvelier C, Remaut E, Veys EM, Mielants H, et al. CARD15 polymorphisms are associated with anti-Saccharomyces cerevisiae antibodies in caucasian Crohn’s disease patients. Clin. Exp. Immunol. 2005; 140:354-9; PMID:15807862; http://dx.doi.org/10.1111/j.1365-2249.2005.02759.x
29. Crane DD, Bauler TJ, Wehrly TD, Bosio CM. Mitochondrial ROS potentiates indirect activation of the AIM2 inflammasome. Front Microbiol 2014; 5:438; PMID:25191316; http://dx.doi.org/10.3389/fmicb.2014.00438
30. Fernandes-Alnemri T, Yu JW, Juliana C, Solorzano LWu J, Datta P, Margaret McCormick, Huang L, McDermott EM, Kang S, Eisenlohr L, et al. The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nature immunology 2010; 11(5):385-93; PMID:20351693; http://dx.doi.org/10.1038/ni.1859
31. Nishikawa Y, Matsuzaki Y, Nakano H, Sawamura D. Characterization of stimulator of interferon genes(sting) expression in human epidermal keratinocytes. Hirosaki Med J. 2013;64(Suppl.):S58:S64.
32. Gupta G, Surolia A. Collectins: sentinels of innate immunity. BioEssays 2007; 29:452-64; PMID:17450595; http://dx.doi.org/10.1002/bies.20573
33. Gal P, Ambrus G. Structure and function of complement activating enzyme complexes: C1 and MBL-MASPs. Curr. Protein Pept. Sci. 2001; 2:43-59; http://dx.doi.org/10.2174/1389203013381242
34. Chaby R. Lipopolysaccharide-binding molecules:transporters, blockers and sensors. Cell. Mol. Life Sci. 2004; 61:1697-713; PMID:15241548; http://dx.doi.org/10.1007/s00018-004-4020-4
35. Bottazzi B, Vouret-Craviari V, Bastone A, Gioia LD, Matteucc C, Peri G, Spreafico F, Pausa M, D’Ettorre C, Gianazza E. Multimer formation and ligand recog- nition by the long pentraxin PTX3. J. Biol. Chem. 1997; 272:32817-32823; PMID:9407058; http://dx.doi.org/10.1074/jbc.272.52.32817
36. Gaboriaud C, Thielens NM, Gregory LA, Rossi V, Fontecilla-Camps JC, Arlaud G. Structure and activation of the C1 complex of complement: unraveling the puzzle. Trends Immunol. 2004; 25:15207504; http://dx.doi.org/10.1016/j.it.2004.04.008
37. Tracey KJ. Physiology and immunology of the cholinergic antiinflammatory pathway. The Journal of Clinical Investigation 2007; 117:289-296; PMID:17273548; http://dx.doi.org/10.1172/JCI30555
38. Cantrell DA. Phosphoinositide 3-kinase signalling path-ways. J. Cell Sci. 2001; 114:1439-45; PMID:11282020
39. McGettrick AF, O’Neil LA. The expanding family of MyD88-like adaptors in Toll-like receptor signal transduction. Mol Immunol. 2004; 41:577-82; PMID:15219996; http://dx.doi.org/10.1016/j.molimm.2004.04.006
40. Goodridge HS, Harnett MM. Introduction to immune cell signalling. Parasitology 2005; 130 Suppl:S3-9; http://dx.doi.org/10.1017/S0031182005008115
41. Delgado MA, Elmaoued RA, Davis AS, Kyei G, Deretic V. Toll-like receptors control autophagy. EMBO J. 2008; 27:1110-21; PMID:18337753; http://dx.doi.org/10.1038/emboj.2008.31
42. Balzola F, Bernstein C, Ho GT, Lees C. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Inflamm. Bowel Dis. Monit. 2010; 10:140-141.
43. Deretic V. Autophagy in immunity and cell-autonomous defense against intracellular microbes. Immunol Rev. 2011; 240:92-104; PMID:21349088; http://dx.doi.org/10.1111/j.1600-065X.2010.00995.x
44. Deretic V. Autophagy as an innate immunity paradigm:expanding the scope and repertoire of pattern recognition receptors. Curr Opin Immunol 2012; 24:21-31; PMID:22118953; http://dx.doi.org/10.1016/j.coi.2011.10.006
45. Eskelinen EL, Saftig P. Autophagy: a lysosomal degradation pathway with a central role in health and disease. Biochim. Biophys. Acta 2009; 1793:664-73.
46. Akhter Y, Ehebauer MT, Mukhopadhyay S, Hasnain SE. The PE/PPE multigene family codes for virulence factors and is a possible source of mycobacterial antigenic variation: Perhaps more? Biochimie 2012; 94:110-116; http://dx.doi.org/10.1016/j.biochi.2011.09.026
47. Galocha B, Hill A, Barnett BC, Dolan A, Raimondi A, Cook RF, Brunner J, McGeoch DJ, Ploegh HL.The active site of ICP47, a Herpes Simplex Virus- encoded inhibitor of the Major Histocompatibility Complex (MHC)-encoded Peptide Transporter Associated with Antigen Processing (TAP), maps to the NH 2 -terminal 35 Residues. J. Exp. Med 1997; 185:1565-1572.
48. Ahn K, Gruhler A, Galocha B, Jones TR, Wiertz EJ, Ploegh HL, Peterson PA, Yang Y, Fruh K. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 1997; 6:613-621; PMID:9175839; http://dx.doi.org/10.1016/S1074-7613(00)80349-0
49. Menz B, Sester M, Koebernick K, Schmid R, Burgert, HG. Structural analysis of the adenovirus type 2 E3/19K protein using mutagenesis and a panel of conformation-sensitive monoclonal antibodies. Mol. Immunol. 2008; 46:16-26; PMID:18692902; http://dx.doi.org/10.1016/j.molimm.2008.06.019
50. Park B, Spooner E, Houser BL, Strominger JL, Ploegh HL. The HCMV membrane glycoprotein US10 selectively targets HLA-G for degradation. J. Exp. Med. 2010; 207:2033-41; PMID:20713594; http://dx.doi.org/10.1084/jem.20091793
51. Brulois K, Toth Z, Wong LY, Feng P, Gao SJ, Ensser A, Jung JU. Kaposi’s sarcoma-associated herpesvirus K3 and K5 ubiquitin E3 ligases have stage-specific immune evasion roles during lytic replication. J Virol 2014; 88:9335-49; PMID:24899205; http://dx.doi.org/10.1128/JVI.00873-14
52. Aquino A, Graziani G, Franzese O, Prete SP, Bonmassar E, Bonmassar L, D’Atri S. Exogenous control of the expression of Group I CD1 molecules competent for presentation of microbial nonpeptide antigens to human T lymphocytes. Clin. Dev. Immunol. 2011; 2011:790460; http://dx.doi.org/10.1155/2011/790460
53. Gagliardi MC, Teloni R, Giannoni F, Mariotti S, Remoli ME, Sargentini V, Videtta M, Pardini M, De Libero G, Coccia EM, et al. Mycobacteria exploit p38 signaling to affect CD1 expression and lipid antigen presentation by human dendritic cells. Infect. Immun. 2009; 77:4947-52; PMID:19720761; http://dx.doi.org/10.1128/IAI.00607-09
54. Gouin E, Cossart P. Actin-based motility of intracellular pathogens. Curr Opin Microbiol 2005; 8:35-45;PMID:15694855; http://dx.doi.org/10.1016/j.mib.2004.12.013
55. Pike LJ. Lipid rafts: bringing order to chaos. J. Lipid Res. 2003; 44:655-67; PMID:12562849; http://dx.doi.org/10.1194/jlr.R200021-JLR200
56. Grassme H, Jendrossek V, Riehle A, von Kurthy G, Berger J, Schwarz H, Weller M, Kolesnick R, Gulbins E. Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. Nat. Med. 2003; 9:322-30; http://dx.doi.org/10.1038/nm823
57. Grassme H, Jekle A, Riehle A, Schwarz H, Berger J, Sandhoff K, Kolesnick R, Gulbins E. CD95 signaling via ceramide-rich membrane rafts. J Biol chem 2001; 276:20589-96; PMID:11279185; http://dx.doi.org/10.1074/jbc.M101207200
58. Gulbins E, Dreschers S, Wilker B, Grassme H. Ceramide, membrane rafts and infections. J.Mol. Med.(Berl). 2004; 82:357-63; PMID:15069600
59. Azenabor AA, Job G, Adedokun OO. Chlamydia pneumoniae infected macrophages exhibit enhanced plasma membrane fluidity and show increased adher- ence to endothelial cells. Mol. Cell. Biochem. 2005; 269:69-84; PMID:15786718; http://dx.doi.org/10.1007/s11010-005-2537-y
60. Simoes AP, Moll GN, Beaumelle B, Vial HJ, Roelofsen B, Op den Kamp JA. Plasmodium knowlesi induces alterations in phosphatidylcholine and phosphatidylethanolamine molecular species com- position of parasitized monkey erythrocytes. Biochim Biophys Acta 1990; 1022:135-45; PMID:2306451; http://dx.doi.org/10.1016/0005-2736(90)90107-Y
61. Rub A, Dey R, Jadhav M, Kamat R, Chakkaramakkil S, Majumdar S, Mukhopadhyaya R, Saha B. Cholesterol depletion associated with Leishmania major infection alters macrophage CD40 signalosome com- position and effector function. Nat. Immunol. 2009; 10:273-80; PMID:19198591; http://dx.doi.org/10.1038/ni.1705
62. Klein A, Mercure L, Gordon P, Bruser B, Ramcharitar S, Malkin A, Wainberg MA. The effect of HIV-1 infection on the lipid fatty acid content in the membrane of cultured lymphocytes. AIDS 1990; 4:865-7; PMID:1979225; http://dx.doi.org/10.1097/00002030-199009000-00005
63. Roy K, Hilliard GM, Hamilton DJ, Luo J, Ostmann MM, Fleckenstein JM. Enterotoxigenic Escherichiacoli EtpA mediates adhesion between flagella and host cells. Nature 2009; 457:594-98; PMID:19060885; http://dx.doi.org/10.1038/nature07568
64. Zhang P, Skurnik M, Zhang SS, Schwartz O, Kalyanasundaram R, Bulgheresi S, He JJ, Klena JD, Hinne-busch BJ, Chen T. Human dendritic cell-specific intercellular adhesion molecule-grabbing nonintegrin (CD209) is a receptor for Yersinia pestis that promotes phagocytosis by dendritic cells. Infec Immun. 2008; 76:2070-9; PMID:18285492
65. Kline KA, Falker S, Dahlberg S, Normark S, Henriques-Normark B. Bacterial adhesins in host-microbe interactions. Cell Host Microbe 2009; 5:580-92; PMID:19527885; http://dx.doi.org/10.1016/j.chom.2009.05.011
66. Joyc, EA, Popper SJ, Falkow S. Streptococcus pneumoniae nasopharyngeal colonization induces type I interferons and interferon-induced gene expression. BMC Genomics 2009; 10:404; PMID:19712482; http://dx.doi.org/10.1186/1471-2164-10-404
67. Blanchette KA, Orihuela CJ. Future perspective on host-pathogen interactions during bacterial biofilm formation within the nasopharynx. Fututre Microbiol 2012; 7:227-239; http://dx.doi.org/10.2217/fmb.11.160
68. Berridge MJ, Irvine RF. Inositol phosphates and cell signalling. Nature 1989; 341:197-205; PMID:2550825; http://dx.doi.org/10.1038/341197a0
69. Nayak DP, Hui EKW. The role of lipid microdomains in virus biology. Subcell. Biochem. 2004; 37:443-91; PMID:15376630
70. Clayton R, Ohagen A, Nicol F, Del Vecchio AM, Jonckers TH, Goethals O, Van Loock M, Michiels L, Grigsby J, Xu Z. Sustained and specific in vitro inhibition of HIV-1 replication by a protease inhibitor encapsulated in gp120-targeted liposomes. Antivir. Res. 2009; 84:142-9; http://dx.doi.org/10.1016/j.antiviral.2009.08.003
71. Rana A, Rub A, Akhter Y. Proteome-scale identification of outer membrane proteins in Mycobacteriumavium subspecies paratuberculosis using a structure based combined hierarchical approach. Mol. Biosyst. 2014; 10:2329-2337; PMID:24950976; http://dx.doi.org/10.1039/C4MB00234B
72. Rana A, Rub A, Akhter Y. Proteome-wide B and T cell epitope repertoires in outer membrane proteins of Mycobacterium avium subsp. paratuberculosis have vaccine and diagnostic relevance: a holistic approach. J Mol Recognit. 2015; PMID:25727233; http://dx.doi.org/10.1002/jmr.2458
73. Liu H, Ibrahim M, Qiu H, Kausar S, Ilyas M, Cui Z, Hussain A, Li B, Waheed A, Zhu B, Xie G. Protein profiling analyses of the outer membrane of Burkholderia cenocepacia reveal a niche-specific proteome. Microb Ecol 2014; 69:75-83; http://dx.doi.org/10.1007/s00248-014-0460-z
74. Alvarez B, Alvarez J, Menendez A, Guijarro J. Amutant in one of two exbD loci of a TonB system in Flavobacterium psychrophilum shows attenuated virulence and confers protection against cold water disease. Microbiology 2008; 154:1144-51; PMID: 18375806; http://dx.doi.org/10.1099/mic.0.2007/010900-0
75. Sandhu P, Akhter Y. The internal gene duplication and interrupted coding sequences in the MmpL of Mycobacterium tuberculosis: Towards understanding the multidrug transport in an evolutionary perspective. Int. J. Med. Microbiol. 2015; 305(3):413-23;PMID:25841626
76. Handzlik J, Matys A, Kiec-Kononowicz K. Recent Advances in Multi-Drug Resistance (MDR) efflux pump inhibitors of gram-positive bacteria S. aureus. Antibiotics 2013; 2:28-45; http://dx.doi.org/10.3390/antibiotics2010028
77. Granoff DM, Ram S, Beernink PT. Does binding of complement factor H to the meningococcal vaccine antigen, factor H binding protein, decrease protective serum antibody responses? Clin. Vaccine Immunol. 2013; 20:1099-107; PMID:23740919; http://dx.doi. org/10.1128/CVI.00260-13
78. Buxbaum LU. Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans. PLoS Negl. Trop. Dis. 2013; 7:e2224; PMID:23675550; http://dx.doi.org/10.1371/journal.pntd.0002224
79. Lin L, Ibrahim AS, Xu X, Farber JM, Avanesian V, Baquir B, Fu Y, French SW, Edwards JE Jr, Spellberg B. Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. PLoS Pathog. 2009; 5: e1000703; PMID:20041174
80. Luo G, Ibrahim AS, Spellberg B, Nobile CJ, Mitchell AP, Fu Y. Candida albicans Hyr1p confers resistance to neutrophil killing and is a potential vaccine target. J Infect Dis. 2010; 201:1718-1728; PMID:20415594; http://dx.doi.org/10.1086/652407
81. Ramana LN, Anand AR, Sethuraman S, Krishnan UM. Targeting strategies for delivery of anti-HIV drugs. J. Control. Release 2014; 192:271-83; http://dx.doi.org/10.1016/j.jconrel.2014.08.003
82. Weiss B, Davidkova G, Zhou LW. Antisense RNA gene therapy for studying and modulating biological. Cell Mol Life Sci. 1999; 55:334-58; PMID:10228554; http://dx.doi.org/10.1007/s000180050296
83. Gebert LF, Rebhan MA, Crivelli SE, Denzler R, Stoffel M, Hall J. Miravirsen (SPC3649) can inhibit the biogenesis of miR-122. Nucleic Acids Res. 2014; 42:609-21; PMID:24068553; http://dx.doi.org/10.1093/nar/gkt852
84. Maganga GD, Kapetshi J, Berthet N, Kebela Ilunga B, Kabange F, Mbala Kingebeni P, Mondonge V, Muyembe JJ, Bertherat E, Briand S. Ebola virus disease in the democratic republic of Congo. N Engl J Med 2014; 371:2083-91; http://dx.doi.org/NEJMoa1411099
85. Carette JE, Raaben M, Wong AC, Herbert AS, Obernosterer G, Mulherkar N, Kuehne AI, Kranzusch PJ, Griffin AM, Ruthel G. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 2011; 477:340-3; PMID:21866103; http://dx.doi.org/10.1038/nature10348
86. Dye C, Henao Restrepo AM, Fast P, Wood D, Dye C, Kieny MP, Moorthy V. Ebola vaccine-an urgent international priority. N Engl J Med 2014; 371:2249-51; http://dx.doi.org/10.1056/NEJMp1412166
87. Rapaport D. How does the TOM complex mediate insertion of precursor proteins into the mitochondrial outer membrane? J. Cell Biol. 2005; 171:419-23; PMID:16260501; http://dx.doi.org/10.1083/jcb.200507147
88. Derre I, Pypaert M, Dautry-Varsat A, Agaisse H. RNAi screen in Drosophila cells reveals the involvement of the Tom complex in Chlamydia infection. PLoS Pathog. 2007; 3:1446-58.
89. Kuijl C, Savage ND, Marsman M, Tuin AW, Janssen L, Egan DA, Ketema M, van den Nieuwendijk R, vanden Eeden SJ, Geluk A, et al. Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1. Nature 2007; 450:725-30; PMID: 18046412; http://dx.doi.org/10.1038/nature06345
90. Granville CA, Memmott RM, Gills JJ, Dennis PA. Handicapping the race to develop inhibitors of the phosphoinositide 3- kinase/Akt/mammalian target of rapamycin pathway. Clin Cancer Res. 2006;12:679-89; PMID:16467077; http://dx.doi.org/10.1158/1078-0432.CCR-05-1654
91. Stanley SA, Barczak AK, Silvis MR, Luo SS, Sogi K, Vokes M, Bray MA, Carpenter AE, Moore CB, Siddiqi N. Identification of host-targeted small molecules that restrict intracellular Mycobacterium tuberculosis growth. PLoS Pathog. 2014; 10:e1003946; PMID:24586159; http://dx.doi.org/10.1371/journal.ppat.1003946
92. Ericson E, Gebbia M, Heisler LE, Wildenhain J, Tyers M, Giaever G, Nislow C. Off-target effects of psychoactive drugs revealed by genome-wide assays in yeast. PLoS Genet. 2008; 4:e1000151; PMID:18688276; http://dx.doi.org/10.1371/journal.pgen.1000151
93. Lieberman LA, Higgins DE. A small-molecule screen identifies the antipsychotic drug pimozide as an inhibitor of Listeria monocytogenes infection. Antimicrob. Agents Chemother. 2009; 53:756-64; PMID:19015342; http:// dx.doi.org/10.1128/AAC.00607-08
94. Lieberman LA, Higgins DE. Inhibition of Listeria monocytogenes infection by neurological drugs. Int J Antimicrob Agents. 2011; 35:1-10.
95. Hong-geller E, Micheva-viteva S. Small Molecule Screens to identify inhibitors of infectious disease.(2013).
96. Sharon A, Shlezinger N. Fungi infecting plants and animals: killers, non-killers, and cell death. PLoS Pathog. 2013; 9:e1003517; PMID:24009499; http:// dx.doi.org/10.1371/journal.ppat.1003517
97. Barnhill AE, Brewer MT, Carlson SA. Adverse effects of antimicrobials via predictable or idiosyncratic inhibition of host mitochondrial components. Antimicrob. Agents Chemother. 2012; 56:4046-51; PMID:22615289; http://dx.doi.org/10.1128/AAC.00678-12
98. Lee SI, Lee JH, Lee SC, Lee JM, Lee JH. Calcium and neostigmine antagonize gentamicin, but augment clindamycin-induced tetanic fade in rat phrenic nerve-hemidiaphragm preparations. J anesth. 2008; 22:385-90; PMID:19011777; http://dx.doi.org/10.1007/s00540-008-0646-y
99. Johnson RF, Cohen AP, Guo Y, Schibler K, Grein-wald JH. Genetic mutations and aminoglycoside:induced ototoxicity in neonates. Otolaryngol Head Neck Surg. 2010; 142:704-7; PMID:20416460; http://dx.doi.org/10.1016/j.otohns.2010.01.030
100. Jurkat-Rott K, Weber MA, Fauler M, Guo XH, Holzherr BD, Paczulla A, Nordsborg N, Joechle W, Lehmann-Horn F. KC-dependent paradoxical membrane depolarization and NaC overload, major and reversible contributors to weakness by ion channel leaks. Proc Natl Acad Sci USA 2009:106:4036-4041; http://dx.doi.org/10.1073/pnas.0811277106
101. Laniado-Laborın R, Cabrales-Vargas MN. Amphotericin B: side effects and toxicity. Rev. Iberoam. Micol. 2009; 26:223-7; http://dx.doi.org/10.1016/j.riam. 2009.06.003